Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Yuejia Pharmaceutical Co., Ltd. is a specialized pharmaceutical manufacturer based in Shaoxing, Zhejiang Province, China. Established in 2001, the company focuses on the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms, particularly in the fields of diabetes management and neurology. Its core product line includes widely prescribed medications such as metformin, gabapentin, and pregabalin. The company operates state-of-the-art, GMP-compliant facilities and has established a significant presence in both the Chinese domestic market and international export markets. Zhejiang Yuejia is recognized for its robust chemical synthesis capabilities and commitment to international quality standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Yuejia Pharmaceuticals.